Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01559649 · ClinicalTrials.gov registry record
Stroke Swallowing Screening Tool Validation
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 284
- Enrollment target
NCT01559649: Completed study, sponsored by VA Office of Research and Development.
NCT01559649 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 284 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01559649 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 284 participants
- Enrollment target
Study Summary
Stroke is a major medical problem in the United States, and veterans are at significant risk given that the most critical risk factors of stroke, older age and associated medical problems such as high blood pressure, are common. Dysphagia, swallowing problems, can lead to aspiration which in turn may result increased pneumonia, particularly in stroke patients. Development and implementation of an accurate and consistent nursing swallowing screening tool to identify risk of aspiration in individuals admitted with suspected stroke is critical as it allows for immediate intervention, thereby reducing associated medical complications, length of stay, and healthcare costs. The availability of such screening tools, however, is limited. The primary objective of this study is to construct a reliable and valid swallowing screening tool to identify risk of aspiration in individuals admitted with suspected stroke.
Primary Outcome
Identify the combination of screenings items that provide the highest level of sensitivity in the identification of aspiration risk as measured by a videofluoroscopic swallow study (VFSS) in individuals admitted with suspected stroke.
Interventions
- BEHAVIORAL Establishing Validity and Reliability
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 284 participants |
| Start Date | 2012-10 |
| Est. Completion | 2015-12 |
What the finished NCT01559649 record still lists
NCT01559649 is an observational study that tracks outcomes without assigning an intervention. The registered 284 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Establishing Validity and Reliability is the first listed.
NCT01559649 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01559649 about?
NCT01559649 is a clinical study titled "Stroke Swallowing Screening Tool Validation". Stroke is a major medical problem in the United States, and veterans are at significant risk given that the most critical risk factors of stroke, older age and associated medical problems such as high blood pressure, are common. Dysphagia, swallowing problems, can lead to aspiration which in turn ma...
What is the current status of trial NCT01559649?
This trial is currently completed. The enrollment target is 284 participants. The study started on 2012-10. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01559649?
The interventions under investigation include: Establishing Validity and Reliability (BEHAVIORAL).
Who is sponsoring clinical trial NCT01559649?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05263206 · 284 participants · Phase 3
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
- NCT05769218 · 284 participants · NA
PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study
- NCT06856577 · 284 participants · Phase 3
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration
- NCT06963034 · 284 participants · Phase 3
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia